{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:39:35Z","timestamp":1774125575705,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1378\/chest.130.1_suppl.41s","type":"journal-article","created":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T02:37:36Z","timestamp":1152758256000},"page":"41S-53S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"S","title":["Side Effects With Inhaled Corticosteroids"],"prefix":"10.1016","volume":"130","author":[{"given":"Richard S.","family":"Irwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.130.1_suppl.41S_bib1","article-title":"National Asthma Education and Prevention Program","year":"1997","journal-title":"Expert panel report 2: guidelines for the diagnosis and management of asthma"},{"key":"10.1378\/chest.130.1_suppl.41S_bib2","first-page":"232","article-title":"Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF","volume":"9","author":"Gilberg","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1378\/chest.130.1_suppl.41S_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2500\/108854199778339071","article-title":"The use of inhaled corticosteroids in asthma","volume":"20","author":"Weltman","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1378\/chest.130.1_suppl.41S_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1472-8206.2003.00191.x","article-title":"Cough after inhalation of corticosteroids delivered from spacer devices in children with asthma","volume":"17","author":"Dubus","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"issue":"5 Suppl","key":"10.1378\/chest.130.1_suppl.41S_bib5","first-page":"S141","article-title":"National Asthma Education and Prevention Program. Expert panel report: guidelines for the diagnosis and management of asthma; update on selected topics 2002","volume":"110","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib6","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1378\/chest.124.6.2329","volume":"124","author":"Leone","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.130.1_suppl.41S_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1034\/j.1398-9995.2001.00100.x","article-title":"Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device","volume":"56","author":"Dubus","year":"2001","journal-title":"Allergy"},{"key":"10.1378\/chest.130.1_suppl.41S_bib8","first-page":"CD003135","article-title":"Inhaled fluticasone propionate for chronic asthma","volume":"3","author":"Adams","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.130.1_suppl.41S_bib9","first-page":"CD003274","article-title":"Budesonide for chronic asthma in children and adults","volume":"4","author":"Adams","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.130.1_suppl.41S_bib10","first-page":"CD003534","article-title":"Inhaled fluticasone at different doses for chronic asthma","volume":"1","author":"Adams","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.130.1_suppl.41S_bib11","first-page":"CD002310","article-title":"Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma","volume":"2","author":"Adams","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1378\/chest.130.1_suppl.41S_bib12","first-page":"A92","article-title":"Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide: results from a pooled analysis [abstract]","volume":"169","author":"Engelst\u00e4tter","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1183\/09031936.00.16580800","article-title":"Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler","volume":"16","author":"Bousquet","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.130.1_suppl.41S_bib14","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2165\/00003495-200161090-00011","article-title":"Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma","volume":"61","author":"Sharpe","year":"2001","journal-title":"Drugs"},{"key":"10.1378\/chest.130.1_suppl.41S_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5694\/j.1326-5377.2003.tb05167.x","article-title":"Inhaled corticosteroid doses in asthma: an evidence-based approach","volume":"178","author":"Powell","year":"2003","journal-title":"Med J Aust"},{"key":"10.1378\/chest.130.1_suppl.41S_bib16","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/j.1572-0241.2003.07626.x","article-title":"Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate","volume":"98","author":"Kanda","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib17","first-page":"1053","article-title":"Esophageal candidiasis as complication of inhaled steroid therapy","volume":"52","author":"Shuto","year":"2003","journal-title":"Arerugi"},{"key":"10.1378\/chest.130.1_suppl.41S_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0091-6749(80)90200-6","article-title":"Candidiasis and dysphonia complicating beclomethasone treatment of asthma","volume":"65","author":"Toogood","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0091-6749(97)70094-0","article-title":"Comparison of antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler","volume":"99","author":"Toogood","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0954-6111(99)90099-9","article-title":"Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler","volume":"93","author":"Bernstein","year":"1999","journal-title":"Respir Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib21","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1183\/09031936.95.08040590","article-title":"Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations","volume":"8","author":"Williamson","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.130.1_suppl.41S_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1378\/chest.116.3.625","article-title":"Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma","volume":"116","author":"Baraniuk","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.130.1_suppl.41S_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003495-200161010-00007","article-title":"Inhaled budesonide\/formoterol combination","volume":"61","author":"McGavin","year":"2001","journal-title":"Drugs"},{"key":"10.1378\/chest.130.1_suppl.41S_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00003495-199957060-00010","article-title":"Salmeterol\/fluticasone propionate combination","volume":"57","author":"Spencer","year":"1999","journal-title":"Drugs"},{"key":"10.1378\/chest.130.1_suppl.41S_bib25","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1378\/chest.124.3.834","article-title":"The efficacy and safety of fluticasone propionate (250 \u03bcg)\/salmeterol (50 \u03bcg) combined in the Diskus inhaler for the treatment of COPD","volume":"124","author":"Hanania","year":"2003","journal-title":"Chest"},{"key":"10.1378\/chest.130.1_suppl.41S_bib26","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1183\/09031936.97.10092127","article-title":"Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers","volume":"10","author":"Pauwels","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.130.1_suppl.41S_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.126.1.213","article-title":"The local side effects of inhaled corticosteroids: current understanding and review of the literature","volume":"126","author":"Roland","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.130.1_suppl.41S_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00003088-200443060-00001","article-title":"Spacer devices for metered dose inhalers","volume":"43","author":"Newman","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.130.1_suppl.41S_bib29","doi-asserted-by":"crossref","first-page":"385a","DOI":"10.1080\/15298668091424933","article-title":"Experimental determination of the regional deposition of aerosol particles in the human respiratory tract","volume":"41","author":"Stahlhofen","year":"1980","journal-title":"Am Ind Hyg Assoc J"},{"key":"10.1378\/chest.130.1_suppl.41S_bib30","doi-asserted-by":"crossref","first-page":"89S","DOI":"10.1378\/chest.120.3_suppl.89S","article-title":"Delivery options and devices for aerosolized therapeutics","volume":"120","author":"Anderson","year":"2001","journal-title":"Chest"},{"issue":"suppl 48","key":"10.1378\/chest.130.1_suppl.41S_bib31","first-page":"583S","article-title":"High lung deposition of 99prTc labelled ciclesonide administered via HFA-MDI to asthma patients [abstract]","volume":"24","author":"Newman","year":"2004","journal-title":"Eur Respir J"},{"issue":"suppl 2","key":"10.1378\/chest.130.1_suppl.41S_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1542\/peds.109.SE1.381","article-title":"Balancing safety and efficacy in pediatric asthma management","volume":"109","author":"Skoner","year":"2002","journal-title":"Pediatrics"},{"key":"10.1378\/chest.130.1_suppl.41S_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00002018-200023010-00002","article-title":"Safety of inhaled and intranasal corticosteroids: lessons for the new millennium","volume":"23","author":"Lipworth","year":"2000","journal-title":"Drug Saf"},{"key":"10.1378\/chest.130.1_suppl.41S_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1465-9921-5-7","article-title":"Significant receptor affinities of metabolites and a degradation product of mometasone furoate","volume":"5","author":"Valotis","year":"2004","journal-title":"Respir Res"},{"key":"10.1378\/chest.130.1_suppl.41S_bib35","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.200404-500OC","article-title":"Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate","volume":"170","author":"Fardon","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl A","key":"10.1378\/chest.130.1_suppl.41S_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0954-6111(97)90102-5","article-title":"Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety","volume":"91","author":"Derendorf","year":"1997","journal-title":"Respir Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib37","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1016\/S0091-6749(03)80757-1","article-title":"PK\/PD of inhaled corticosteroids: the risk\/benefit of inhaled ciclesonide [abstract]","volume":"111","author":"Rohatagi","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib38","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(00)02581-2","article-title":"Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study","volume":"356","author":"Brutsche","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.130.1_suppl.41S_bib39","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2165\/00003088-200342060-00003","article-title":"Deposition and effects of inhaled corticosteroids","volume":"42","author":"Newman","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1378\/chest.130.1_suppl.41S_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.122.2.618","article-title":"Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate","volume":"122","author":"Fowler","year":"2002","journal-title":"Chest"},{"key":"10.1378\/chest.130.1_suppl.41S_bib41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-2125.1999.00098.x","article-title":"Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate","volume":"48","author":"Lipworth","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib43","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1359\/jbmr.1998.13.8.1283","article-title":"Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids","volume":"13","author":"Ebeling","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1378\/chest.130.1_suppl.41S_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","article-title":"Use of inhaled corticosteroids and risk of fractures","volume":"16","author":"van Staa","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1378\/chest.130.1_suppl.41S_bib45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0091-6749(93)90263-F","article-title":"Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthma","volume":"91","author":"Toogood","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.130.1_suppl.41S_bib47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00001648-200103000-00016","article-title":"The risk of cataract among users of inhaled steroids","volume":"12","author":"Jick","year":"2001","journal-title":"Epidemiology"},{"key":"10.1378\/chest.130.1_suppl.41S_bib48","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/S0161-6420(99)90530-4","article-title":"Inhaled corticosteroids, family history, and risk of glaucoma","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1378\/chest.130.1_suppl.41S_bib49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1542\/peds.92.2.223","article-title":"Severe varicella associated with steroid use","volume":"92","author":"Dowell","year":"1993","journal-title":"Pediatrics"},{"key":"10.1378\/chest.130.1_suppl.41S_bib50","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00006454-199509000-00017","article-title":"Severe varicella after low dose inhaled corticosteroids","volume":"14","author":"Choong","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1378\/chest.130.1_suppl.41S_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1159\/000050552","article-title":"Effects of amphotericin B gargles on oral colonization ofCandida albicansin asthmatic patients on steroid inhalation therapy","volume":"68","author":"Fukushima","year":"2001","journal-title":"Respiration"},{"key":"10.1378\/chest.130.1_suppl.41S_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thx.46.12.891","article-title":"Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler","volume":"46","author":"Selroos","year":"1991","journal-title":"Thorax"},{"key":"10.1378\/chest.130.1_suppl.41S_bib53","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMe068007","article-title":"Calcium plus vitamin D for postmenopausal women: bone app\u00e9tit [editorial]?","volume":"354","author":"Finkelstein","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.130.1_suppl.41S_bib55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1378\/chest.130.1_suppl.41S_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00063198-200201000-00008","article-title":"Growth effects of asthma and asthma therapy","volume":"8","author":"Skoner","year":"2002","journal-title":"Curr Opin Pulm Med"},{"issue":"4 Suppl","key":"10.1378\/chest.130.1_suppl.41S_bib57","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1542\/peds.106.S3.886","article-title":"Self-reported physician practices for children with asthma: are national guidelines followed?","volume":"106","author":"Finkelstein","year":"2000","journal-title":"Pediatrics"},{"key":"10.1378\/chest.130.1_suppl.41S_bib58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1081-1206(10)62989-4","article-title":"Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists","volume":"80","author":"Storms","year":"1998","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215329561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215329561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:44:15Z","timestamp":1757918655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215329561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0012369215329561"],"URL":"https:\/\/doi.org\/10.1378\/chest.130.1_suppl.41s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Side Effects With Inhaled Corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.130.1_suppl.41S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}